Understanding Alzheimer's disease using chimpanzees
Alzheimer's Disease Pathology in a Primate Model
This study looks at how Alzheimer's disease affects the brains of chimpanzees, which can help us learn more about the disease and find better treatments for people with Alzheimer's.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11010761 on NIH RePORTER |
What this research studies
This research investigates Alzheimer's disease (AD) pathology by studying chimpanzees, which naturally develop key features of the disease, including amyloid-beta plaques and neurofibrillary tangles. The research team aims to analyze the brain changes associated with aging and cognitive decline in these animals, providing insights into the disease's etiology. By examining various biomarkers and neurovascular conditions, the study seeks to enhance our understanding of AD and potentially guide new therapeutic approaches. This work utilizes advanced pathologic analyses to quantify the extent of AD-related changes in the chimpanzee brain.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at risk for Alzheimer's disease or those experiencing early cognitive decline.
Not a fit: Patients with advanced Alzheimer's disease or those who do not have any cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and therapeutic strategies for treating Alzheimer's disease in humans.
How similar studies have performed: Previous studies using animal models have shown promise in understanding Alzheimer's disease, but this approach using chimpanzees is relatively novel.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Hopkins, William D — University of Tx Md Anderson Can Ctr
- Study coordinator: Hopkins, William D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.